Verastem (VSTM) Other Working Capital Changes (2011 - 2026)
Verastem (VSTM) recorded quarterly Other Working Capital Changes of $857000.0 in Q1 2026, up 21.22% quarter-over-quarter from $707000.0 in Q4 2025, and up 137020.0% on a YoY basis from N/an in Q1 2025.
Verastem (VSTM) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Verastem's Other Working Capital Changes history runs 16 years deep, the most recent figure standing at $857000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 137020.0% year-over-year to $857000.0; the TTM figure through Mar 2026 stood at -$1.4 million (down 216900.0% YoY), while the FY2025 annual figure was $1997.0, changed 0.0% from the prior year.
- Other Working Capital Changes was $857000.0 for Q1 2026 at Verastem, up from $707000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.1 million in Q4 2022 to a low of -$2.2 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged $8527.8 across 5 years, with a median of $12415.0 in 2023.
- The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes slumped 218.13% in 2022, then jumped 137020.0% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at $2.1 million in 2022, then tumbled by 134.39% to -$708000.0 in 2023, then plunged by 212.29% to -$2.2 million in 2024, then soared by 131.98% to $707000.0 in 2025, then climbed by 21.22% to $857000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $857000.0 (Q1 2026), $707000.0 (Q4 2025), and $625.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 857,000.00 |
| Mar 31, 2026 | 857,000.00 |
| Dec 31, 2025 | 707,000.00 |
| Dec 31, 2025 | 707,000.00 |
| Sep 30, 2025 | 625.00 |
| Sep 30, 2025 | 625.00 |
| Jun 30, 2025 | 625.00 |
| Jun 30, 2025 | 625.00 |
| Mar 31, 2025 | 625.00 |
| Mar 31, 2025 | 625.00 |
| Dec 31, 2024 | -2.21 Mn |
| Dec 31, 2024 | -2.21 Mn |
| Sep 30, 2024 | 23,677.00 |
| Sep 30, 2024 | 23,677.00 |
| Jun 30, 2024 | 23,677.00 |
| Jun 30, 2024 | 23,677.00 |
| Mar 31, 2024 | 22,914.00 |
| Mar 31, 2024 | 22,914.00 |
| Dec 31, 2023 | -708,000.00 |
| Dec 31, 2023 | -708,000.00 |